Calixar

Specializes in the functional and native isolation of complex therapeutic targets & antigens

placeLyon, Auvergne Rhone Alpes, France calendar_todayFounded 2011 groups19 employees language calixar.com

Innovation

5 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 208 times.

YearFilings
20141
20151
20164
20174
20182
20193
20202
20211

Social engagement

Social engagement: 4.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital113%
Private equity225%
Angel & family office225%
Bank & private debt113%
Other / undisclosed225%

Recent activity

21 Oct 2025
Event
ELRIG Drug Discovery 2025
20 Oct 2025
Event
ELRIG Drug Discovery 2025
14 Oct 2025
Event
ELRIG Drug Discovery 2025
Coming soon